Atlas Trials

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Clinical trial NCT01722149 · COMPLETED

Trial details

NCT number
NCT01722149
Sponsor
University of Zurich
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Malignant Pleural Mesothelioma
Start date
2015-02-19
Primary completion
2019-03-22
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.